Skip to main content

Articles

Page 235 of 330

  1. The electronic self report assessment - cancer (ESRA-C), has been shown to reduce symptom distress during cancer therapy The purpose of this analysis was to evaluate aspects of how the ESRA-C intervention may ...

    Authors: Donna L Berry, Fangxin Hong, Barbara Halpenny, Anne Partridge, Erica Fox, Jesse R Fann, Seth Wolpin, William B Lober, Nigel Bush, Upendra Parvathaneni, Dagmar Amtmann and Rosemary Ford
    Citation: BMC Cancer 2014 14:513
  2. To prospectively assess circulating tumor cell (CTC) status at baseline (CTCBL) and after one cycle of a new line of systemic therapy (CTC1C), and changes from CTCBL to CTC1C (CTC kinetics, CTCKIN) for their util...

    Authors: Markus Wallwiener, Sabine Riethdorf, Andreas Daniel Hartkopf, Caroline Modugno, Juliane Nees, Dharanija Madhavan, Martin Ronald Sprick, Sarah Schott, Christoph Domschke, Irène Baccelli, Birgitt Schönfisch, Barbara Burwinkel, Frederik Marmé, Jörg Heil, Christof Sohn, Klaus Pantel…
    Citation: BMC Cancer 2014 14:512
  3. New biomarkers are needed for the prognosis of advanced colorectal cancer, which remains incurable by conventional treatments. O6-methylguanine DNA methyltransferase (MGMT) methylation and protein expression have...

    Authors: Jaime Antonio Oliver, Raúl Ortiz, Consolación Melguizo, Pablo Juan Álvarez, Jaime Gómez-Millán and Jose Prados
    Citation: BMC Cancer 2014 14:511
  4. Nintedanib is a potent, oral angiokinase inhibitor that targets VEGF, PDGF and FGF signalling, as well as RET and Flt3. The maximum tolerated dose of nintedanib was evaluated in a phase I study of treatment-re...

    Authors: Klaus Mross, Martin Büchert, Annette Frost, Michael Medinger, Peter Stopfer, Matus Studeny and Rolf Kaiser
    Citation: BMC Cancer 2014 14:510
  5. Tetraspanins are transmembrane proteins that serve as scaffolds for multiprotein complexes containing, for example, integrins, growth factor receptors and matrix metalloproteases, and modify their functions in...

    Authors: Séverine Roselli, Richard GS Kahl, Ben T Copeland, Matthew J Naylor, Judith Weidenhofer, William J Muller and Leonie K Ashman
    Citation: BMC Cancer 2014 14:509
  6. Non-small cell lung cancer (NSCLC) patients with interstitial lung disease (ILD) need to be approached carefully given the high incidence of pulmonary toxicity. Pemetrexed (PEM) is the key drug for the treatme...

    Authors: Motoyasu Kato, Takehito Shukuya, Fumiyuki Takahashi, Keita Mori, Kentaro Suina, Tetsuhiko Asao, Ryota Kanemaru, Yuichiro Honma, Keiko Muraki, Koji Sugano, Rina Shibayama, Ryo Koyama, Naoko Shimada and Kazuhisa Takahashi
    Citation: BMC Cancer 2014 14:508
  7. Vinflunine (VFL) is a microtubule-targeting drug that suppresses microtubule dynamics, showing anti-metastatic properties both in vitro and in living cancer cells. An increasing body of evidence underlines the in...

    Authors: Luis A Aparicio, Raquel Castosa, Mar Haz-Conde, Marta Rodríguez, Moisés Blanco, Manuel Valladares and Angélica Figueroa
    Citation: BMC Cancer 2014 14:507
  8. Grade IV glioblastomas exist in two forms, primary (de novo) glioblastomas (pGBM) that arise without precursor lesions, and the less common secondary glioblastomas (sGBM) which develop from earlier lower grade le...

    Authors: Victoria K Hill, Thoraia Shinawi, Christopher J Ricketts, Dietmar Krex, Gabriele Schackert, Julien Bauer, Wenbin Wei, Garth Cruickshank, Eamonn R Maher and Farida Latif
    Citation: BMC Cancer 2014 14:506
  9. Few studies consider both the survival and financial benefits of detection of invasive cervical cancer (ICC) at earlier stages. This study estimated the savings in life-years and costs from early diagnosis of ...

    Authors: Mei-Chuan Hung, Meng-Ting Liu, Ya-Min Cheng and Jung-Der Wang
    Citation: BMC Cancer 2014 14:505
  10. The combination platinum, 5-fluorouracil (5-FU) and cetuximab is the standard first-line regimen of recurrent and/or metastatic head and neck squamous cell carcinoma (HNSCC). Due to the toxicity of this treatm...

    Authors: Julien Péron, Valentine Polivka, Sylvie Chabaud, Marc Poupart, Philippe Ceruse, Antoine Ramade, Didier Girodet, Philippe Zrounba and Jérôme Fayette
    Citation: BMC Cancer 2014 14:504
  11. The approval of epoetin biosimilars in the European Union requires extensive scientific evaluation and stringent regulatory procedures, including post-marketing studies. The ORHEO (place of biOsimilaRs in the ...

    Authors: Mauricette Michallet, Elisabeth Luporsi, Pierre Soubeyran, Nadia Ali Amar, Vincent Boulanger, Miguel Carreiro, Louis-Marie Dourthe, Jean-Luc Labourey, Daniel Lepille, Frédéric Maloisel, Jean-Loup Mouysset, Sophie Nahon, Bérengère Narciso, Pierre Nouyrigat, Raouf Radji, Nacéra Sakek…
    Citation: BMC Cancer 2014 14:503

    The Erratum to this article has been published in BMC Cancer 2014 14:720

  12. We previously showed that human papillomavirus (HPV) serostatus was not an independent risk factor for esophageal squamous cell carcinoma(ESCC) in nonsmokers and nondrinkers; however, HPV increased the risk in...

    Authors: Ju Yang, Huanlei Wu, Sheng Wei, Huihua Xiong, Xiangning Fu, Zhaozhen Qi, Qian Jiang, Wen Li, Guangyuan Hu, Xianglin Yuan and Zhongxing Liao
    Citation: BMC Cancer 2014 14:501
  13. At present, there are no widely accepted criteria for the use of radiofrequency ablation (RFA) for the treatment of colorectal liver metastases (CLM) in the context of effective modern-agent therapies. We aime...

    Authors: Axel Stang, Karl Jürgen Oldhafer, Hauke Weilert, Handan Keles and Marcello Donati
    Citation: BMC Cancer 2014 14:500
  14. The microenvironment modulates tissue specificity in the normal breast and in breast cancer. The stromal loss of CD34 expression and acquisition of SMA myofibroblastic features may constitute a prerequisite fo...

    Authors: Xavier Catteau, Philippe Simon and Jean-Christophe Noël
    Citation: BMC Cancer 2014 14:499
  15. Colorectal cancer (CRC) is the second most common malignancy in Europe and a leading cause of cancer-related death. Almost 50% of patients with CRC develop liver metastases, which heralds a poor prognosis unle...

    Authors: Susan J Dutton, Nicola Kenealy, Sharon B Love, Harpreet S Wasan and Ricky A Sharma
    Citation: BMC Cancer 2014 14:497
  16. Multiple myeloma is an incurable haematological cancer that affects physical, psychological and social domains of quality of life (QOL). Treatment decisions are increasingly guided by QOL issues, creating a ne...

    Authors: Thomas R Osborne, Christina Ramsenthaler, Susanne de Wolf-Linder, Stephen A Schey, Richard J Siegert, Polly M Edmonds and Irene J Higginson
    Citation: BMC Cancer 2014 14:496
  17. Growing evidence exists that the neoplastic stromal cell population (GCTSC) within giant cell tumors (GCT) originates from mesenchymal stem cells (MSC). In a previous study we identified a microRNA signature t...

    Authors: Burkhard Lehner, Pierre Kunz, Heiner Saehr and Joerg Fellenberg
    Citation: BMC Cancer 2014 14:495
  18. Podocalyxin (PODXL) is a transmembrane sialomucin, whose aberrant expression and/or allelic variation associates with poor prognosis and unfavourable clinicopathological characteristics in different cancers. M...

    Authors: Tuomas Kaprio, Jaana Hagström, Christian Fermér, Harri Mustonen, Camilla Böckelman, Olle Nilsson and Caj Haglund
    Citation: BMC Cancer 2014 14:494
  19. Over two decades ago, a proposal was that two different colorectal cancer (CRC) entities existed, based on tumour location either proximal (right) or distal (left) of the splenic flexure. Proximal and distal t...

    Authors: Tuomas Kaprio, Christian Fermér, Jaana Hagström, Harri Mustonen, Camilla Böckelman, Olle Nilsson and Caj Haglund
    Citation: BMC Cancer 2014 14:493
  20. The preoperative characterization of thyroid nodules is a challenge for the clinicians. Fine-needle aspiration (FNA) is the commonly used pre-operative technique for diagnosis of malignant thyroid tumor. Howev...

    Authors: Vanessa Arcolia, Paula Paci, Ludovic Dhont, Gilbert Chantrain, Nicolas Sirtaine, Christine Decaestecker, Myriam Remmelink, Alexandra Belayew and Sven Saussez
    Citation: BMC Cancer 2014 14:492
  21. The objective of this study was to evaluate the radiation dose and response in terms of local-regional progression-free survival (LRPFS) and overall survival (OS) of patients with stage IV non-small cell lung ...

    Authors: Wei-Wei Ouyang, Sheng-Fa Su, Yin-Xiang Hu, Bing Lu, Zhu Ma, Qing-Song Li, Hui-Qin Li and Yi-Chao Geng
    Citation: BMC Cancer 2014 14:491
  22. Elevated serum YKL-40 levels have been observed in various cancers. We evaluated the diagnostic performance of serum YKL-40 alone or in combination with the CEA, CYFRA21-1 and SCCA tumor markers for patients w...

    Authors: Xin Zheng, Shan Xing, Xiao-Min Liu, Wen Liu, Dan Liu, Pei-Dong Chi, Hao Chen, Shu-Qin Dai, Qian Zhong, Mu-Sheng Zeng and Wan-Li Liu
    Citation: BMC Cancer 2014 14:490
  23. Regulatory T cells (Tregs) exhibit functional abnormalities in the context of hepatocellular carcinoma (HCC). The microRNAs (miRNAs) are identified as the key modulators in Tregs. This study was to explore whe...

    Authors: Long Chen, Huiying Ma, Heng Hu, Lingling Gao, Xuan Wang, Jiaqi Ma, Qiang Gao, Binbin Liu, Guomin Zhou and Chunmin Liang
    Citation: BMC Cancer 2014 14:489
  24. The methylation of DNA is recognized as a key epigenetic mechanism and evidence for its role in the development of several malignancies is accumulating. We evaluated the relationship between global methylation...

    Authors: Will D King, Janet E Ashbury, Sherryl A Taylor, M Yat Tse, Stephen C Pang, Jacob A Louw and Stephen J Vanner
    Citation: BMC Cancer 2014 14:488
  25. Mechanisms governing the metastasis of endometrial cancer (EC) are poorly defined. Recent data support a role for Enhancer-of-split and hairy-related protein 1 (SHARP1), a basic helix-loop-helix transcription ...

    Authors: Yun Liao, Xiaoying He, Haifeng Qiu, Qi Che, Fangyuan Wang, Wen Lu, Zheng Chen, Meiting Qiu, Jingyun Wang, Huihui Wang and Xiaoping Wan
    Citation: BMC Cancer 2014 14:487
  26. Evasion of immune surveillance and suppression of the immune system are important hallmarks of tumorigenesis. The goal of this study was to establish distinct patterns that reflect a rectal tumors’ immune-phen...

    Authors: Marlies S Reimers, Charla C Engels, Hein Putter, Hans Morreau, Gerrit Jan Liefers, Cornelis JH van de Velde and Peter JK Kuppen
    Citation: BMC Cancer 2014 14:486
  27. To compare pain response outcomes for patients with spinal bone metastases treated with resistance training of the spinal musculature versus passive physical therapy during radiotherapy (RT).

    Authors: Harald Rief, Thomas Welzel, Georg Omlor, Michael Akbar, Thomas Bruckner, Stefan Rieken, Matthias F Haefner, Ingmar Schlampp, Alexandros Gioules and Jürgen Debus
    Citation: BMC Cancer 2014 14:485
  28. Recent reports support a novel biological phenomenon about cancer related neurogenesis. However, little is known about the clinicopathological significance of neurogenesis in breast cancer.

    Authors: Qianqian Zhao, Yan Yang, Xizi Liang, Guangye Du, Liwei Liu, Lingjuan Lu, Junbo Dong, Hongxiu Han and Guohua Zhang
    Citation: BMC Cancer 2014 14:484
  29. Chk1 inhibitors are currently in clinical trials in combination with a range of cytotoxic agents and have the potential to potentiate the clinical activity of a large number of standard of care chemotherapeuti...

    Authors: Rebecca Rawlinson and Andrew J Massey
    Citation: BMC Cancer 2014 14:483
  30. Metastasis to the breast from nonmammary malignancies is rare, and mostly involves patients in a pre-terminal condition with systemic metastases outside the breast. Lymphoma and leukemia, melanoma, and lung ca...

    Authors: Masahiro Yokouchi, Satoshi Nagano, Yuko Kijima, Takako Yoshioka, Akihide Tanimoto, Shoji Natsugoe and Setsuro Komiya
    Citation: BMC Cancer 2014 14:482
  31. The role of omega-3 polyunsaturated fatty acids (ω3-PUFAs) in cancer prevention has been demonstrated; however, the exact molecular mechanisms underlying the anticancer activity of ω3-PUFAs are not fully under...

    Authors: Soyeon Jeong, Kaipeng Jing, Nayeong Kim, Soyeon Shin, Soyeon Kim, Kyoung-Sub Song, Jun-Young Heo, Ji-Hoon Park, Kang-Sik Seo, Jeongsu Han, Tong Wu, Gi-Ryang Kweon, Seung-Kiel Park, Jong-Il Park and Kyu Lim
    Citation: BMC Cancer 2014 14:481
  32. Both Wnt5a overexpression and macrophage infiltration have been implicated in inflammation and cancer. The aim of this study is to reveal the involvement of Wnt5a in macrophage recruitment in gastric cancer.

    Authors: Shengjun Li, Wei Wang, Ning Zhang, Tingxian Ma and Chenghai Zhao
    Citation: BMC Cancer 2014 14:480
  33. Altered expression of astrocyte elevated gene-1 (AEG-1) is associated with tumorigenesis and progression. The present study aimed to investigate the clinical and prognostic significance of AEG-1 expression in ...

    Authors: Yan Huang, Guo-Ping Ren, Chao Xu, Shui-Feng Dong, Ying Wang, Yun Gan, Li Zhu and Tian-Yuan Feng
    Citation: BMC Cancer 2014 14:479
  34. CHEK2 is a multi-cancer susceptibility gene whose common germline mutations are known to contribute to the risk of developing breast and prostate cancer.

    Authors: Gianluca Tedaldi, Rita Danesi, Valentina Zampiga, Michela Tebaldi, Lucia Bedei, Wainer Zoli, Dino Amadori, Fabio Falcini and Daniele Calistri
    Citation: BMC Cancer 2014 14:478
  35. RhoC is a small G protein/GTPase and involved in tumor mobility, invasion and metastasis. Previously, up-regulated RhoC expression is found to play an important role in ovarian carcinogenesis and subsequent pr...

    Authors: Wen-feng Gou, Yang Zhao, Hang Lu, Xue-feng Yang, Yin-ling Xiu, Shuang Zhao, Jian-min Liu, Zhi-tu Zhu, Hong-zhi Sun, Yun-peng Liu, Feng Xu, Yasuo Takano and Hua-chuan Zheng
    Citation: BMC Cancer 2014 14:477
  36. Combination of fluoropyrimidines and a platinum derivative are currently standards for systemic chemotherapy in advanced adenocarcinoma of the stomach and gastroesophageal junction (GEJ). Nevertheless, individ...

    Authors: Thomas Thomaidis, Annett Maderer, Salah-Eddin Al-Batran, Janis Kany, Claudia Pauligk, Kristina Steinmetz, Arno Schad, Ralf Hofheinz, Harald Schmalenberg, Nils Homann, Peter Robert Galle and Markus Moehler
    Citation: BMC Cancer 2014 14:476
  37. Genome-wide linkage studies have identified the 9q22 chromosomal region as linked with colorectal cancer (CRC) predisposition. A candidate gene in this region is transforming growth factor β receptor 1 (TGFBR1...

    Authors: Jason P Ross, Linda J Lockett, Bruce Tabor, Ian W Saunders, Graeme P Young, Finlay Macrae, Ignacio Blanco, Gabriel Capella, Glenn S Brown, Trevor J Lockett and Garry N Hannan
    Citation: BMC Cancer 2014 14:475
  38. Socioeconomic inequalities in cancer mortality in Britain have been shown to be present in the 1990s and early 2000s. Little is known about on-going patterns in such inequalities in cancer mortality. We examin...

    Authors: Sheena E Ramsay, Richard W Morris, Peter H Whincup, Anna Olia Papacosta, Lucy T Lennon and Sasiwarang Goya Wannamethee
    Citation: BMC Cancer 2014 14:474
  39. Patients with recurrent and/or metastatic (R/M) head and neck squamous cell carcinoma (HNSCC) receiving platinum-based chemotherapy as their first-line treatment have a dismal prognosis, with a median overall ...

    Authors: Jean-Pascal H Machiels, Lisa F Licitra, Robert I Haddad, Makoto Tahara and Ezra EW Cohen
    Citation: BMC Cancer 2014 14:473
  40. Matrix metalloproteinases (MMPs) are involved in cancer invasion and metastasis. Circulating tumor cells (CTCs) play role in tumor dissemination and are an independent survival predictor in breast cancer (BC) ...

    Authors: Zuzana Cierna, Michal Mego, Pavol Janega, Marian Karaba, Gabriel Minarik, Juraj Benca, Tatiana Sedlácková, Silvia Cingelova, Paulina Gronesova, Denisa Manasova, Daniel Pindak, Jozef Sufliarsky, Ludovit Danihel, James M Reuben and Jozef Mardiak
    Citation: BMC Cancer 2014 14:472
  41. Advanced pancreatic cancer confers poor prognosis and treatment advancement has been slow. Recent randomized clinical trials (RCTs) have demonstrated survival benefits for combination therapy compared to gemci...

    Authors: Gillian K Gresham, George A Wells, Sharlene Gill, Christopher Cameron and Derek J Jonker
    Citation: BMC Cancer 2014 14:471
  42. Genetic predisposition is the primary risk factor for familial breast cancer. For the majority of familial breast cancer, however, the genetic predispositions remain unknown. All newly identified predispositio...

    Authors: Hongxiu Wen, Yeong C Kim, Carrie Snyder, Fengxia Xiao, Elizabeth A Fleissner, Dina Becirovic, Jiangtao Luo, Bradley Downs, Simon Sherman, Kenneth H Cowan, Henry T Lynch and San Ming Wang
    Citation: BMC Cancer 2014 14:470
  43. Several epidemiological studies have previously investigated the association between the TP53 codon 72 polymorphism and oral squamous cell carcinoma (OSCC) susceptibility; however, current results are inconsisten...

    Authors: Xian-Tao Zeng, Wei Luo, Pei-Liang Geng, Yi Guo, Yu-Ming Niu and Wei-Dong Leng
    Citation: BMC Cancer 2014 14:469
  44. Diagnosing adipocytic tumors can be challenging because it is often difficult to morphologically distinguish between benign, intermediate and malignant adipocytic tumors, and other sarcomas that are histologic...

    Authors: Taro Sasaki, Akira Ogose, Hiroyuki Kawashima, Tetsuo Hotta, Hiroshi Hatano, Takashi Ariizumi, Hajime Umezu, Riuko Ohashi, Tsuyoshi Tohyama, Naohito Tanabe and Naoto Endo
    Citation: BMC Cancer 2014 14:468
  45. Breast cancer affects one in eight UK women during their lifetime: many of these women now receive adjuvant chemotherapy and hormone therapy. Joint and muscle pains, aches, and stiffness are common but the nat...

    Authors: Deborah Fenlon, Cassandra Powers, Peter Simmonds, Joanne Clough and Julia Addington-Hall
    Citation: BMC Cancer 2014 14:467
  46. Recent work led to recognize sessile serrated adenomas (SSA) as precursor to many of the sporadic colorectal cancers with microsatellite instability (MSI). However, comprehensive analyses of DNA methylation in...

    Authors: Yuta Muto, Takafumi Maeda, Koichi Suzuki, Takaharu Kato, Fumiaki Watanabe, Hidenori Kamiyama, Masaaki Saito, Kei Koizumi, Yuichiro Miyaki, Fumio Konishi, Sergio Alonso, Manuel Perucho and Toshiki Rikiyama
    Citation: BMC Cancer 2014 14:466
  47. The goal of this study was to determine the prognostic factors associated with an improved overall outcome after stereotactic body radiotherapy (SBRT) for primary lung cancer and metastatic lung tumors.

    Authors: Takaya Yamamoto, Keiichi Jingu, Yuko Shirata, Masashi Koto, Haruo Matsushita, Toshiyuki Sugawara, Masaki Kubozono, Rei Umezawa, Keiko Abe, Noriyuki Kadoya, Youjirou Ishikawa, Maiko Kozumi, Noriyoshi Takahashi, Ken Takeda and Yoshihiro Takai
    Citation: BMC Cancer 2014 14:464

Featured videos

View featured videos from across the BMC-series journals